Ibrexafungerp - CISMeF

Preferred Label : Ibrexafungerp;

NCIt synonyms : IBX;

NCIt definition : An intravenous and orally bioavailable semisynthetic derivative of enfumafungin with potential antifungal activity. Upon administration, ibrexafungerp inhibits beta-1,3-D-glucan synthase, an enzyme essential for fungal cell wall synthesis. This results in weakening of the fungal cell wall, thereby leading to osmotic lysis and eventually fungal cell death.;

UNII : A92JFM5XNU;

InChIKey : BODYFEUFKHPRCK-ZCZMVWJSSA-N;

CAS number : 1207753-03-4;

Molecule name : MK-3118; MK 3118; SCY-078; SCY 078;

Details

Origin ID

C162185;

UMLS CUI

C5206403;

Currated CISMeF NLP mapping
- ibrexafungerp [MeSH Supplementary Concept]
- ibrexafungerp [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- ibrexafungerp [MeSH Supplementary Concept]
- ibrexafungerp [ATC Code]
Validated automatic mappings to BTNT
- ibrexafungerp [ATC Code]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients